These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 30637502)
1. Predicting locally advanced rectal cancer response to neoadjuvant therapy with Giannini V; Mazzetti S; Bertotto I; Chiarenza C; Cauda S; Delmastro E; Bracco C; Di Dia A; Leone F; Medico E; Pisacane A; Ribero D; Stasi M; Regge D Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):878-888. PubMed ID: 30637502 [TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Lovinfosse P; Polus M; Van Daele D; Martinive P; Daenen F; Hatt M; Visvikis D; Koopmansch B; Lambert F; Coimbra C; Seidel L; Albert A; Delvenne P; Hustinx R Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):365-375. PubMed ID: 29046927 [TBL] [Abstract][Full Text] [Related]
3. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488 [TBL] [Abstract][Full Text] [Related]
4. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822 [TBL] [Abstract][Full Text] [Related]
5. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer. Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180 [TBL] [Abstract][Full Text] [Related]
6. Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study. Vuijk FA; Feshtali Shahbazi S; Noortman WA; van Velden FHP; Dibbets-Schneider P; Marinelli AWKS; Neijenhuis PA; Schmitz R; Ghariq E; Velema LA; Peters FP; Smit F; Peeters KCMJ; Temmink SJD; Crobach SALP; Putter H; Vahrmeijer AL; Hilling DE; de Geus-Oei LF Nucl Med Commun; 2023 Jul; 44(7):613-621. PubMed ID: 37132268 [TBL] [Abstract][Full Text] [Related]
7. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958 [TBL] [Abstract][Full Text] [Related]
8. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study. Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192 [TBL] [Abstract][Full Text] [Related]
9. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC). Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063 [TBL] [Abstract][Full Text] [Related]
10. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer. Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624 [TBL] [Abstract][Full Text] [Related]
11. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038 [TBL] [Abstract][Full Text] [Related]
12. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer. Nishimura J; Hasegawa J; Ogawa Y; Miwa H; Uemura M; Haraguchi N; Hata T; Yamamoto H; Takemasa I; Mizushima T; Nezu R; Doki Y; Mori M Surg Today; 2016 Oct; 46(10):1152-8. PubMed ID: 26711129 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy. Capelli G; Campi C; Bao QR; Morra F; Lacognata C; Zucchetta P; Cecchin D; Pucciarelli S; Spolverato G; Crimì F Nucl Med Commun; 2022 Jul; 43(7):815-822. PubMed ID: 35471653 [TBL] [Abstract][Full Text] [Related]
14. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731 [TBL] [Abstract][Full Text] [Related]
15. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer]. Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327 [TBL] [Abstract][Full Text] [Related]
16. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501 [TBL] [Abstract][Full Text] [Related]
17. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial. Guido A; Cuicchi D; Castellucci P; Cellini F; Di Fabio F; Llimpe FLR; Strigari L; Buwenge M; Cilla S; Deodato F; Macchia G; Galietta E; Golfieri R; Ardizzoni A; Zagari RM; Fanti S; Poggioli G; Fuccio L; Morganti AG Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416 [TBL] [Abstract][Full Text] [Related]
18. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275 [TBL] [Abstract][Full Text] [Related]
19. Predicting the pathological response to chemoradiotherapy of non-mucinous rectal cancer using pretreatment texture features based on intravoxel incoherent motion diffusion-weighted imaging. Liu S; Wen L; Hou J; Nie S; Zhou J; Cao F; Lu Q; Qin Y; Fu Y; Yu X Abdom Radiol (NY); 2019 Aug; 44(8):2689-2698. PubMed ID: 31030244 [TBL] [Abstract][Full Text] [Related]
20. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation. Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]